Alchemyca Biotech | $2,500,000 | (Nov 22, 2024)
OneCell Diagnostics Inc. | $16,000,000 | (Nov 22, 2024)
Iontra Inc | $45,000,000 | (Nov 22, 2024)
Qase
United States
- San Francisco, California
- 28/08/2023
- Series A
- $6,700,000
Qase is an all-in-one test management platform built to beautifully orchestrate QA for both manual and automated testing. Users love our intuitive UI and powerful features, including test case management, defect management, test plans, test runs with informative reports, a rich API, and webhooks. Qase offers integrations with the most popular issue trackers like Jira, Asana, Slack, and dozens more.
- Industry Software Development
- Website https://qase.io/
- LinkedIn https://www.linkedin.com/company/qaseio/about/
Related People
Nikita FedorovFounder
United States -
Austin, Texas
Founder and CEO at Qase.io - test management platform for Dev and QA teams, trusted by Meetup, Exante, Crypto.com
We’re changing the traditional landscape of testing by providing an intuitive TMS that simplifies life for Dev and QA teams. We believe that managing test cases, plans, runs and defects can be easy and joyful.
We allow you to customise Qase to emulate your system layout. If you need a very specific feature to meet your QA needs - simply let us know, we’re quick to respond and focused on finding solutions.
Contact me at nikita@qase.io
Enveda | $130,000,000 | (Nov 22, 2024)
Shinami | $5,645,000 | (Nov 22, 2024)
DANNCE.ai | $2,600,000 | (Nov 22, 2024)
Trustero | $10,000,000 | (Nov 22, 2024)
Dote | $1,447,585 | (Nov 22, 2024)
CredFlow | $3,700,000 | (Nov 22, 2024)
Lighthouse (UK) | $370,000,000 | (Nov 22, 2024)
Faircraft | $15,800,000 | (Nov 22, 2024)
Clean Skin Club | $32,000,000 | (Nov 22, 2024)